In Depth 10 Jun 2024 ASCO 2024: The latest advances in oncology clinical trials Biotechs from all over the country as well as other parts of the world showcased recent pipeline advancements in oncology clinical trials at ASCO 2024. June 10, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 6 Jun 2024 Eight biotech companies advancing the field of siRNA Explore the growing sector of siRNA and discover eight biotech companies spearheading this innovative field. June 6, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Jun 2024 Evolving standards of care: new treatments for cervical cancer New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients. June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 May 2024 Covalent biologics: a new class of drugs on the horizon The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic. May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 22 May 2024 The undruggable cancer target: KRAS inhibitors move ahead in the clinic Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout. May 22, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about. May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by Lumicks 14 May 2024 Cell avidity-tuning ensures safe CAR-T therapy for solid tumors Learn more about the potential of cell avidity in designing potent and safe CAR-T treatments for solid tumors. May 14, 2024 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 9 May 2024 BTK inhibitors: can these drugs tackle cancer and autoimmunity? BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases. May 9, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times. May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Apr 2024 Overcoming toxicities: are IL-2 smart cytokines the next big thing? A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it. April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Apr 2024 Eight biotechnology companies leading the charge in Poland Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups. April 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2024 Seven biotech companies climbing their way up in Colorado We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates. April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email